1 Chong VF,Ong CK.Nasopharyngeal carcinoma[J].Eur J Radiol,2008,66(3): 437-447.
2于金明.21世纪的放射肿瘤学[J].中华肿瘤杂志,2002,24(6):521-525.
3秦朝军,黄盛才,王仁生,等.~(18)F-FDG PET/CT显像诊断原发鼻咽癌的价值[J].广西医学,2008,4:474-476.
4 Comoretto M,Balestreri L,Borsatti E,et al.Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT[J].Radiology,2008,249 (1):203-211.
5于金明,刘宁波.非小细胞肺癌表皮生长因子受体分子影像研究进展[J].中华肿瘤杂志,2009,2:81-84.
6罗耀武,唐安戊,徐卫平.~(18)F-FDG PET显像诊断原发性鼻咽癌的价值[J].中华核医学,2003 5:271-.274.
7潘衍基,冯彦林,卫光宇.~(18)F-FDG PET显像在鼻咽癌诊断治疗中的价值[J] .中国肿瘤临床,2004,8:444-446.
8 Yen RF,Chen TH,Ting LL,et al.Early restaging whole-body(18) F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma[J].Eur J Nucl Med Mol Imaging, 2005,32(10):1152-59.
9 Lee SW,Nam SY,Im KC,et al.Prediction of prognosis using standardized uptake value of 2-[(18) F]fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinornas[J].Radiother Oncol,2008,87(2):211-216.
10 Yen TC,Chang YC,Chan SC,et al.Are dual-phase ~(18)F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes[J]? Eur J Nucl Med Mol Imaging,2005,32(5):541-548.
11 Chan SC,Chang JT,Wang HM,et al.Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma:the role of standardized uptake value [J].Oral Oncol,2009,45(1):52-58.
12 Chan SC,Ng SH,ChangJ T,et al.Advantages and pitfalls of 18F-fluoro-2-deoxy -D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma:comparison with magnetic resonance imaging [J].EurJ Nucl Med Mol Imaging,2006,33(9):1032-40.
13 Gordin A,Golz A,Daitzchman M,et al.Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx:diagnostic accuracy and impact on clinical management [J].Int J Radiat Oncol Biol Phys,2007,68(2):370-376.
14 Yen TC,Lin CY,Wang HM,et al.~(18)F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys, 2006,65(5):1307-14.
15 Chang JT,Chan SC,Yen TC,et al.Nasopharyngeal carcinoma staging by(18) F-fluorodeoxyglucose positron emission tomography[J].Int J Radiat Oncol Biol Phys,2005,62(2):501-507.
16 Ng SH,Chang JT,Chan SC,et al.Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET[J].Eur J Nucl Med Mol Imaging, 2004,31(8):1073-80.
17 King AD,Ma BB,Yau YY,et al.The impact of ~(18)F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis[J].Br J Radiol,2008,81(964): 291-298.
18 Sheng CC,Tzu CY,Shu HN,et al.18-fluoro-2-deoxyglucose positron emission tomograhy in detecting residual/recuurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging[J].Cancer,2003,98:283-287.
19 Liu T,Xu W,Yan WL,et al.FDG-PET,CT,MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma,which one is the best? A systematic review[J].Radiother Oncol,2007,85(3):327-335.
20 Tsai MH,Shiau YC,Kao CH,et al.Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy [J].J Cancer Res Clin Oncol,2002,128(5):279-282.
21 Ling CC,Humm J,Larson S,et al.Towards multidimensional radiotherapy (MD-CRT):biological imaging and biological conformality[J].Int J Radiat Oncol Biol Phys,2000,47:551-560.
22 Zheng XK,Chen LH,Wang QS,et al.Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma [J].Int J Radiat Oncol Biol Phys,2007,69(5):1381-88.
23 Grosu AL,Piert M,Weber WA,et al.Positron emission tomography for radiation treatment planning[J].Strahlenther Onkol,2005,181(8):483-499.
24 Breen SL,PublicoverJ,De-SilvaS,etal.Intraobserver and interobserver varia- bility in GTV delineation on FDG-PET-CT images of head and neck cancers[J]. Int J Radiat Oncol Biol Phys,2007,68(3):763-770.
25 Murakami R,Uozumi H,Hirai T,et al.Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma:intermethod and interobserver variations[J].Acta Radiol,2008,49(6):693-699.
26 Guido A,Fuccio L,Rombi B,et al.Combined ~(18)F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer[J].Int J Radiat Oncol Biol Phys,2009,73(3):759-763.
27 Wang D,Schultz CJ,Jursinic PA,et al.Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma[J].Int J Radiat Oncol Biol Phys, 2006,65(1):143-151.
28 Paulino AC,Koshy M,Howell R,et al.Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer[J].Int J Radiat Oncol Biol Phys,2005,61(5):1385-92.
29 Schinagl DA,Vogel WV,Hoffmann AL,et al.Comparison of five segmentation tools for ~(18)F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer[J].Int J Radiat Oncol Biol Phys, 2007,69(4):1282-89.
30 El-Bassiouni M,Ciernik IF,Davis JB,et al.[~(18)FDG]PET-CT-based intensity -modulated radiotherapy treatment planning of head and neck cancer[J].Int J Radiat Oncol Biol Phys,2007,69(1):286-293. |